Breaking News

Meet the 2023 STAT Wunderkinds

October 17, 2023

Meet the 2023 STAT Wunderkinds

Search for next-generation superstars in biotech and life sciences now in its seventh year. These are the 2023 STAT Wunderkinds.

By STAT Staff


STAT+ | It's time for the FDA to halt Cassava Sciences' Alzheimer's clinical trials

Some thoughts on the fallout from the CUNY investigation that raised serious doubts about the experimental drug simufilam.

By Adam Feuerstein


STAT+ | Our expensive obesity drugs are worth it, Novo Nordisk and Eli Lilly argue in raft of studies

Yet many of the studies, being presented at ObesityWeek, don't include the considerable cost of obesity drugs like Ozempic and Mounjaro.

By Elaine Chen



Lotte Bjerre Knudsen, a chief scientific adviser at Novo Nordisk whose passionate belief in harnessing GLP-1 biology was instrumental to the company's success in developing Ozempic and Wegovy.
Illustration: Christine Kao/STAT; Courtesy: Lotte Bjerre Knudsen

STAT+ | How one scientist's determination made Novo Nordisk an obesity-drug powerhouse

"It was only Lotte's enthusiasm that made it at all possible to get anywhere," said one of Knudsen's scientific collaborators.

By Megan Molteni


Measuring the long-term cost of restricting abortion access

In her groundbreaking Turnaway study, MacArthur grantee Diana Greene Foster measured the health and economic cost of denying abortions.

By Annalisa Merelli


STAT+ | Revenue cycle management company Waystar files for IPO

Revenue cycle management company Waystar filed for an initial public offering Monday with the Securities and Exchange Commission.

By Brittany Trang


Adobe

STAT+ | When Medicare paid doctors differently, fewer patients had heart problems

Doctors lowered the incidence of heart disease and strokes among their patients when Medicare rewarded them for focusing on sicker patients.

By John Wilkerson


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments